COR2ED Medical Education

How can new clinical trials in radioligand therapy impact clinical practice in #NET treatment strategies?

Find out in this new #MedEd video from medical experts

cor2ed.com/net-connect/...

Supported by an Independent Educational Grant from ITM

@nanets.bsky.social #MedSky #medicaleducation 📷

Improving acne vulgaris with multimodal treatment strategies | COR2ED In this micro learning module, developed by experts Prof. Alison Layton and Prof. Dr Falk Ochsendorf, you will explore multimodal treatment strategies for

📢 New #dermatology micro learning!

Improving acne vulgaris with multimodal treatment strategies

>> cor2ed.com/dermatology-...

📺 4-min video, downloadable flashcard & slides, and accredited assessment

Supported by an Independent Educational Grant from Glenmark Pharmaceuticals

#MedSky

ADC breast cancer trials to look out for in 2025 ⬇️

#MedSky #MedEd

🔎 Expert insights on recent #BreastCancer data

Dr Paolo Tarantino discusses data from SERENA-6, ASCENT-04/KEYNOTE-D19 & DESTINY-Breast09 studies presented at #ASCO25

Watch his video & see more ASCO updates
▶️ cor2ed.com/n-connect/pr...

Supported by COR2ED #MedEd #MedSky @ptarantinomd.bsky.social

Early relapsed/refractory multiple myeloma (RRMM): best practices in management | COR2ED

🚨 Best practices in managing early relapsed/refractory multiple myeloma

3-part video series with expert insights & downloadable slide sets
⬇️
cor2ed.com/lymphoma-mye...

Supported by an Independent Educational Grant from Menarini Stemline Oncology

#MedSky #MedEd #RRMM

Navigating advanced HCC: treatment strategies beyond immunotherapy (IO) | COR2ED In this micro learning, developed by experts Assoc. Prof. Lorenza Rimassa and Dr Amit Singal, you will learn about treatment strategies for patients who

➡️Tx strategies for pts w/ advanced #HCC who are ineligible for #immunotherapy or with progression on #IO

👉 cor2ed.com/hcc-connect/...

Endorsed by @digestivecancerseu.bsky.social @bluefaeryliver.bsky.social @aasldnews.bsky.social @europeliver.bsky.social

Supported by an IME Grant from Bayer #meded

Congratulations to the newly elected ESMO Directors & Nomination Committee members!

A special mention to:
👏 GI CONNECT's Dr @lizzysmyth.bsky.social
👏 PRECISION ONCOLOGY CONNECT's Prof. Ulrik Lassen
👏 Prof. Rachel Riechelmann, who has collaborated with NET CONNECT

#MedicalEducation #ESMO #MedSky

Rethinking hypophosphatasia (HPP) diagnosis and disease burden | COR2ED

📹 Watch the video > cor2ed.com/n-connect/pr...

Video: The evolution of our understanding that led us to rethink #hypophosphatasia (HPP) 💡

w/ Dr Chad Deal

Programme initiated & funded by Alexion Pharmaceuticals. Intended for healthcare professionals only. GL/UNB-H/0074

#MedEd #MedSky #EULAR2025

Highlights from ASCO 2025 | COR2ED

📣Update from #ASCO25

Expert insights on the latest data: cor2ed.com/n-connect/pr...

#NSCLC #ProstateCancer #GICancer #BreastCancer #OvarianCancer #CervicalCancer

NSCLC update supported by an Independent Educational Grant from Bayer.Other updates supported by COR2ED

#MedEd @lizzysmyth.bsky.social

Rethinking hypophosphatasia (HPP) diagnosis and disease burden | COR2ED

📹 Watch the video: cor2ed.com/n-connect/pr...

Video: Recognising #hypophosphatasia (HPP)🔍

- Key manifestations
- Common misdiagnoses

w/ Dr Chad Deal

Programme initiated & funded by Alexion Pharmaceuticals. Intended for healthcare professionals only. GL/UNB-H/0074

#MedEd #EULAR2025

ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium | COR2ED In this conference update video, Profs. Wolfgang Janni, Sherko Kümmel and Michail Ignatiadis provide key insights from the highly anticipated ESMO Breast

📣Highlights from #ESMO Breast Cancer 2025 Satellite Symposium

Experts discuss treatment strategies/sequencing after ET+CDK4/6i for ER+/HER2- metastatic #breastcancer

cor2ed.com/n-connect/pr...

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only

Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) | COR2ED Metastatic pancreatic ductal adenocarcinoma (mPDAC) is notoriously aggressive, with a poor prognosis. It is often diagnosed late, and by this time,

Chemotherapy strategies in mPDAC

➡️How to choose & optimise the different chemotherapeutic options at 1st & 2nd line

w/ Profs. Efrat Dotan & Shubham Pant

📹 Watch the video/listen on Spotify/Apple cor2ed.com/gi-connect/p...

Supported by an Independent Educational Grant from Ipsen USA

#MedEd

Chemotherapy strategies for metastatic pancreatic ductal adenocarcinoma | COR2ED In this 2-part video animated series, medical oncologists Prof Eileen O’Reilly and Prof Efrat Dotan provide an overview of the different treatment options

New 2-part animated video series! 🎬

Ep.1 ➡️ 1st line chemotherapy options, key trial data & considering targeted therapy

Ep.2 ➡️ 2nd line chemotherapy options & how earlier treatments impact sequencing

cor2ed.com/gi-connect/p...

Supported by an Independent Educational Grant from Ipsen USA

#MedEd

The HER2 diagnostic and treatment landscape in NSCLC: Episode 2 | COR2ED This is the second episode of a two-part series on the HER2 diagnostic and treatment landscape in non-small cell lung cancer (NSCLC), hosted by the

🎙️#MedEd podcast

'The #HER2 diagnostic and treatment landscape in #NSCLC'

> Ep. 2: Navigating common treatment scenarios in HER2-mutant NSCLC

➡️w/ @oncbrothers.bsky.social

Watch the video/listen on Spotify/Apple:
cor2ed.com/lung-connect...

Supported by an Independent Educational Grant from Bayer

The HER2 diagnostic and treatment landscape in NSCLC: Episode 1 | COR2ED This is the first episode of a two-part series on the HER2 diagnostic and treatment landscape in non-small cell lung cancer (NSCLC), hosted by the

📢 New #lungcancer podcast!

'The #HER2 diagnostic and treatment landscape in #NSCLC'

>> Episode 1: Identifying HER2-directed NSCLC

w/@oncbrothers.bsky.social

Watch the video/listen on Spotify/Apple👇
cor2ed.com/lung-connect...

Supported by an Independent Educational Grant from Bayer

#MedEd

Survey on the evolving role of the oncology nurse in the USA | COR2ED Access the paper online here: The Evolving Role of the Oncology Nurse in the United States of America.   The survey results highlight:  How roles and

What do oncology nurses in the USA think about the ways their roles are changing?

GI NURSES CONNECT set out to answer this question in a recent survey 📊

The findings were published in the journal 'Healthcare'

Find out more: cor2ed.com/gi-nurses-co...

Supported by an IME grant from Bayer

#MedEd

The expanding role of immunotherapy in HCC | COR2ED In this micro learning developed by experts Prof. Aiwu Ruth He and Prof. Beau Toskich, you’ll learn about the expanding role of immunotherapy (IO) in

HCC micro learning 🎓

The expanding role of immunotherapy in HCC

> Combining locoregional & systemic treatments in intermediate HCC

Video, slides, flashcard + accredited assessment
👉 cor2ed.com/hcc-connect/...

AstraZeneca has provided a sponsorship grant towards this independent programme
#MedEd

ESMO Virtual Plenary: Final OS results from the phase III TROPION-Breast01 trial | COR2ED Prof. François-Clément Bidard and Dr Barbara Pistilli share expert insights on the latest TROPION-Breast01 update, presenting the final OS results from

TROPION-Breast01 final OS results did not reach statistical significance; however, subsequent ADC Tx may have influenced survival outcomes

Update on the latest data from #ESMO Virtual Plenary 2025👇
cor2ed.com/breast-cance...

Supported by an Independent Educational Grant from AstraZeneca

#MedEd

LEAP-012 publication snapshot | COR2ED Discover insights from the Phase 3 LEAP-012 study evaluating lenvatinib + pembrolizumab + TACE versus double placebo + TACE for patients with intermediate

📢 Key insights from the Phase 3 LEAP-012 study

➡️Lenvatinib + pembrolizumab + TACE versus double placebo + TACE for patients with intermediate #HCC

w/Prof. @arndtvogel.bsky.social

cor2ed.com/hcc-connect/...

This Independent programme has been sponsored by Eisai Europe Limited ("Eisai")

#MedEd

ER+ metastatic breast cancer: Highlights from the 13th APBCS Satellite Symposium | COR2ED In this conference update video, Profs. Shaheenah Dawood, Heather McArthur, Javier Cortés, and Frédérique Penault-Llorca provide key insights from the

➡️ #Breastcancer highlights from the 13th #APBCS Satellite Symposium

w/ Profs. Dawood, McArthur, Cortés & Penault-Llorca

Watch the video update👉 cor2ed.com/n-connect/pr...

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only

#MedEd #Oncology

HR+/HER2- metastatic breast cancer: Best practices in molecular testing and targeted therapy | COR2ED Join Dr Rena Callahan and Dr Roberto Salgado as they explore the latest insights in molecular testing and targeted therapy for HR+/HER2- metastatic breast

📣New video podcast!

➡️ Exploring the latest insights in #moleculartesting & targeted therapy for HR+/HER2- metastatic breast cancer

w/ Dr Callahan & Dr Salgado

Listen on Spotify/Apple : cor2ed.com/precision-on...

Supported by an Independent Educational Grant from Thermo Fisher Scientific

#MedEd

Current and future treatment strategies for patients with ER+/HER2- early breast cancer | COR2ED In this conference update video, Profs. Michael Gnant and Giuseppe Curigliano provide key insights from the highly anticipated 19th St. Gallen Breast

ER+/HER2- early #breastcancer: Current & future Tx strategies

📺 Profs. Gnant & Curigliano share an update from #SGBCC2025

See more + get the slides
👉 cor2ed.com/n-connect/pr...

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only

#MedEd

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions | COR2ED The treatment landscape for advanced and recurrent endometrial cancer (EC) is evolving, with molecular classification playing a key role in guiding

New #MedEd video podcast from #OBGYN experts

‘Molecular classification and treatment decisions in advanced or recurrent #endometrialcancer’

Watch/listen
👉 cor2ed.com/obstetrics-g...

This independent programme has been sponsored by Eisai Europe Limited ("Eisai").

#MedEd #Oncology